Valuation: RPG Life Sciences Limited

Market Cap 44.7B 467M 403M 379M 345M 648M 658M 4.45B 1.74B 22.36B 1.75B 1.71B 74.47B P/E 2027 *
34x
P/E 2028 * 27.5x
Enterprise Value 44.7B 467M 403M 379M 345M 648M 658M 4.45B 1.74B 22.36B 1.75B 1.71B 74.47B EV / Sales 2027 *
5.47x
EV / Sales 2028 * 4.84x
Free-Float
24.7%
Yield 2027 *
0.59%
Yield 2028 * 0.73%
1 day-1.41%
1 week+2.45%
Current month-2.37%
1 month-5.49%
3 months+17.89%
6 months+37.08%
Current year+16.38%
1 week 2,604
Extreme 2604
2,867
1 month 2,604
Extreme 2604
3,082
Current year 1,733
Extreme 1733
3,082
1 year 1,733
Extreme 1733
3,082
3 years 1,138.55
Extreme 1138.55
3,082
5 years 450.55
Extreme 450.55
3,082
10 years 142.95
Extreme 142.95
3,082
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 2025-12-14
Compliance Officer - 2011-11-10
Director TitleAgeSince
Chairman 68 2008-02-05
Director/Board Member 57 2015-01-22
Director/Board Member 68 2015-12-31
Date Insider Type Main position Quantity % Market Cap.
3/12/25
Nucleus Life Trust
BuyCompany 3,048 0.0184%
3/12/25
Nucleus Life Trust
BuyCompany 1,859 0.0112%
3/12/25
Nucleus Life Trust
BuyCompany 4,412 0.0267%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%+2.45%+19.45%+131.75% 474M
+3.60%+0.88%+75.59%+124.32% 1,055B
+3.33%+4.35%+53.82%+57.17% 632B
+3.43%+3.53%+25.34%+72.45% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+1.75%-0.24%+25.28%+40.46% 290B
+2.13%-1.53%+1.85%+9.40% 243B
+1.41%+2.65%+45.34%+62.43% 227B
+1.35%-3.20%-9.07%-53.51% 200B
+3.25%+5.65%+21.57%+89.04% 172B
Average +2.02%-0.19%+30.01%+57.50% 361.3B
Weighted average by Cap. +2.79%-0.18%+44.09%+68.29%

Financials

2027 *2028 *
Net sales 8.17B 85.23M 73.61M 69.26M 62.95M 118M 120M 812M 318M 4.08B 320M 313M 13.6B 9.24B 96.41M 83.27M 78.34M 71.2M 134M 136M 919M 360M 4.62B 362M 354M 15.39B
Net income 1.32B 13.72M 11.85M 11.15M 10.14M 19.07M 19.34M 131M 51.27M 658M 51.53M 50.41M 2.19B 1.62B 16.95M 14.64M 13.77M 12.52M 23.55M 23.89M 162M 63.32M 812M 63.64M 62.26M 2.71B
Net Debt - -
Logo RPG Life Sciences Limited
RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.
Employees
1,366
Date Price Change Volume
26-08-18 ₹2,702.70 -1.41% 11,456
26-08-17 ₹2,741.30 -1.47% 14,587
26-08-14 ₹2,782.30 -1.70% 14,339
26-08-13 ₹2,830.50 +8.34% 79,874
26-08-12 ₹2,612.70 -0.79% 6,528

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPGLIFE Stock